Detalhe da pesquisa
1.
Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
N Engl J Med;
387(20): 1865-1876, 2022 11 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36322837
2.
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
N Engl J Med;
386(19): 1804-1816, 2022 05 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35263534
3.
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
N Engl J Med;
387(1): 21-34, 2022 07 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35704396
4.
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
N Engl J Med;
385(24): e83, 2021 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34614327
5.
Enhancing the notification system for surveillance of infectious diseases in Qatar during the FIFA World Cup 2022: project overview.
BMC Public Health;
24(1): 625, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38413899
6.
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design.
Am J Epidemiol;
2023 Dec 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38061757
7.
Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar.
Virol J;
20(1): 188, 2023 08 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37608372
8.
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
Clin Infect Dis;
75(1): e1188-e1191, 2022 08 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34657152
9.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Clin Infect Dis;
73(7): e1830-e1840, 2021 10 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33315061
10.
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
Emerg Infect Dis;
27(5): 1343-1352, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33900174
11.
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
PLoS Med;
18(12): e1003879, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34914711
12.
Protection against Reinfection with the Omicron BA.2.75 Subvariant.
N Engl J Med;
388(7): 665-667, 2023 02 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36652342
13.
Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
Epidemiol Infect;
149: e193, 2021 07 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34210371
14.
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
JAMA;
326(19): 1930-1939, 2021 11 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34724027
15.
Bordetella pertussis: An agent not to be forgotten in Qatar.
Qatar Med J;
2021(1): 10, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34604009
16.
Pre-symptomatic and asymptomatic transmission of COVID-19: Implications for control measures in Qatar.
Qatar Med J;
2021(3): 59, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34745912
17.
Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.
N Engl J Med;
387(17): 1620-1622, 2022 10 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36198139
18.
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
N Engl J Med;
386(13): 1288-1290, 2022 03 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35139269
19.
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.
N Engl J Med;
387(18): 1716-1718, 2022 11 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36223534
20.
Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013-2017.
BMC Infect Dis;
20(1): 617, 2020 Aug 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32819294